Literature DB >> 9824208

The expression pattern of the Hmgic gene during development.

U Hirning-Folz1, M Wilda, V Rippe, J Bullerdiek, H Hameister.   

Abstract

The technique of RNA in situ hybridization to mouse embryo sections from different developmental stages was used to perform a detailed analysis of the expression pattern of the gene for the architectural chromatin factor Hmgic. At early stages of fetal development (day 9.5 post conceptionem), Hmgic is expressed at a high rate throughout the whole embryo. In the second half of development, the pattern of expression becomes more restricted. Expression is found in mesenchymal derivatives, which differentiate into cartilage or muscle, in epithelial cell layers of the lung, pancreas, submandibular gland, and vibrissae, and in some special parts of the central nervous system. The expression pattern of Hmgic was compared with the previously reported studies of Hmgiy gene expression, another member of the Hmgic protein family, and with the expression of histone H4, Hist4, which is representative of cellular proliferation stages. In some tissues the pattern of expression for both factors coincides, but in others the expression is different. Hmgic expression correlates throughout fetal development with high proliferative activity. In contrast, Hmgiy is expressed also in tissues with no proliferative activity, such as the cortical plate of the telencephalon and the spinal cord at late gestational stages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824208

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  38 in total

1.  Let-7 represses Nr6a1 and a mid-gestation developmental program in adult fibroblasts.

Authors:  Allan M Gurtan; Arvind Ravi; Peter B Rahl; Andrew D Bosson; Courtney K JnBaptiste; Arjun Bhutkar; Charles A Whittaker; Richard A Young; Phillip A Sharp
Journal:  Genes Dev       Date:  2013-04-15       Impact factor: 11.361

2.  HMGI-C suppressing induces P53/caspase9 axis to regulate apoptosis in breast adenocarcinoma cells.

Authors:  Behzad Mansoori; Ali Mohammadi; Solmaz Shirjang; Behzad Baradaran
Journal:  Cell Cycle       Date:  2016-05-31       Impact factor: 4.534

3.  HMGA1 expression in human gliomas and its correlation with tumor proliferation, invasion and angiogenesis.

Authors:  Bo Pang; Haitao Fan; Ian Y Zhang; Bin Liu; Bin Feng; Lei Meng; Rui Zhang; Sam Sadeghi; Hua Guo; Qi Pang
Journal:  J Neurooncol       Date:  2011-10-08       Impact factor: 4.130

4.  Silencing of High Mobility Group Isoform I-C (HMGI-C) Enhances Paclitaxel Chemosensitivity in Breast Adenocarcinoma Cells (MDA-MB-468).

Authors:  Behzad Mansoori; Ali Mohammadi; Samira Goldar; Dariush Shanehbandi; Leila Mohammadnejad; Elham Baghbani; Tohid Kazemi; Saeed Kachalaki; Behzad Baradaran
Journal:  Adv Pharm Bull       Date:  2016-06-30

5.  Expression profiling of uterine leiomyomata cytogenetic subgroups reveals distinct signatures in matched myometrium: transcriptional profilingof the t(12;14) and evidence in support of predisposing genetic heterogeneity.

Authors:  Jennelle C Hodge; Tae-Min Kim; Jonathan M Dreyfuss; Priya Somasundaram; Nicole C Christacos; Marissa Rousselle; Bradley J Quade; Peter J Park; Elizabeth A Stewart; Cynthia C Morton
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

6.  Targeting HMGA2 in Retinoblastoma Cells in vitro Using the Aptamer Strategy.

Authors:  Venkatesan Nalini; Perinkulam Ravi Deepa; Rajeswari Raguraman; Vikas Khetan; Maddy Ashwin Reddy; Subramanian Krishnakumar
Journal:  Ocul Oncol Pathol       Date:  2016-07-02

7.  Transcriptomic analysis of the developing and adult mouse cochlear sensory epithelia.

Authors:  Ibtihel Smeti; Said Assou; Etienne Savary; Saber Masmoudi; Azel Zine
Journal:  PLoS One       Date:  2012-08-10       Impact factor: 3.240

8.  Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferation.

Authors:  Kai-Yin Chau; Guidalberto Manfioletti; Kam-Wa Cheung-Chau; Alfredo Fusco; Nathalie Dhomen; Jane C Sowden; Tetsuo Sasabe; Shizuo Mukai; Santa Jeremy Ono
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

9.  Prognostic value of HMGA2, CDK4, and JUN amplification in well-differentiated and dedifferentiated liposarcomas.

Authors:  Esma Saâda-Bouzid; Fanny Burel-Vandenbos; Dominique Ranchère-Vince; Isabelle Birtwisle-Peyrottes; Bruno Chetaille; Corinne Bouvier; Marie-Christine Château; Michel Peoc'h; Maxime Battistella; Audrey Bazin; Jocelyn Gal; Jean-François Michiels; Jean-Michel Coindre; Florence Pedeutour; Laurence Bianchini
Journal:  Mod Pathol       Date:  2015-09-04       Impact factor: 7.842

10.  HMGA2 exhibits dRP/AP site cleavage activity and protects cancer cells from DNA-damage-induced cytotoxicity during chemotherapy.

Authors:  Heike Summer; Ou Li; Qiuye Bao; Lihong Zhan; Sabrina Peter; Padmapriya Sathiyanathan; Dana Henderson; Thomas Klonisch; Steven D Goodman; Peter Dröge
Journal:  Nucleic Acids Res       Date:  2009-05-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.